Breaking News Instant updates and real-time market news.

DEA

Easterly Government Properties

$20.99

0.18 (0.86%)

, PMC

PharMerica

$29.25

0.05 (0.17%)

18:14
12/07/17
12/07
18:14
12/07/17
18:14

S&P announces changes to S&P SmallCap 600 index

S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Easterly Government Properties (DEA) will replace PharMerica (PMC) effective prior to the open of trading on Tuesday, December 12. KKR (KKR) and affiliates acquired PharMerica in a transaction completed December 7. Cutera (CUTR) will replace Tesco (TESO) effective prior to the open of trading on Friday, December 15. S&P MidCap 400 constituent Nabors Industries (NBR) is acquiring Tesco in a deal expected to be completed on or about that date, pending final conditions.

DEA

Easterly Government Properties

$20.99

0.18 (0.86%)

PMC

PharMerica

$29.25

0.05 (0.17%)

KKR

KKR

$19.66

0.47 (2.45%)

CUTR

Cutera

$40.60

1.1 (2.78%)

TESO

Tesco

$4.05

0.1 (2.53%)

NBR

Nabors Industries

$6.08

0.13 (2.18%)

  • 07

    Dec

  • 14

    Dec

  • 15

    May

DEA Easterly Government Properties
$20.99

0.18 (0.86%)

01/09/17
RAJA
01/09/17
DOWNGRADE
RAJA
Market Perform
Easterly Government Properties downgraded to Market Perform at Raymond James
Raymond James analyst William Crow downgraded Easterly Government Properties to Market Perform from Outperform citing recent strong performance since the IPO.
PMC PharMerica
$29.25

0.05 (0.17%)

08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
08/04/17
FBCO
08/04/17
DOWNGRADE
FBCO
Neutral
PharMerica downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Erin Wilson Wright downgraded PharMerica (PMC) to Neutral from Outperform, citing the company's agreement to be acquired by a newly formed company controlled by KKR (KKR), with Walgreens Boots Alliance (WBA) as a minority investor.
08/03/17
BRRR
08/03/17
DOWNGRADE
BRRR
Underperform
PharMerica downgraded to Underperform from Outperform at Barrington
Barrington analyst Michael Petusky double downgraded PharMerica (PMC) to Underperform saying other takeover bidders are unlikely to emerge. The analyst suggests redeploying proceeds into Tivity Health (TVTY), Primo Water (PRMW), U.S. Physical Therapy (USPH) and OPKO Health (OPK).
08/02/17
LEER
08/02/17
NO CHANGE
LEER
AmerisourceBergen may benefit from PharMerica takeover, says Leerink
Leerink analyst David Larsen believes AmerisourceBergen (ABC) could benefit from KKR's (KKR) buyout of PharMerica (PMC). KKR and Walgreens Boots Alliance (WBA), which uses AmerisourceBergen as a supplier, are forming a new private company which would hold PharMerica, Larsen tells investors in a research note. He believes PharMerica may switch away from its current supplier Cardinal Health (CAH) as a result of today's deal and use AmerisourceBergen. Any potential change in distributor contracts would likely occur in the second half of 2018, the analyst adds.
KKR KKR
$19.66

0.47 (2.45%)

10/16/17
GSCO
10/16/17
UPGRADE
GSCO
Buy
KKR upgraded to Buy from Neutral at Goldman Sachs
Goldman analyst Alexander Blostein upgraded KKR to Buy and raised its price target to $24 from $23 to reflect a more stable, improving mix of balance sheet investments, lower concentration in large public holdings, and increased mix towards private holdings.
11/01/17
WELS
11/01/17
NO CHANGE
WELS
Wells Fargo dropping coverage of WebMD
Wells Fargo is dropping equity research coverage of WebMD (WBMD) following completion of the company's acquisition by Internet Brands, a KKR (KKR) portfolio company.
11/28/17
SDLR
11/28/17
INITIATION
Target $21
SDLR
Hold
KKR resumed with a Hold at Sandler ONeill
Sandler O'Neill resumed coverage of KKR with a Hold rating and $21 price target.
10/16/17
10/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) was upgraded to Overweight from Sector Weight at KeyBanc and Pacific Crest. 2. Infinera (INFN) upgraded to Neutral from Sell at Citi with analyst Stanley Kovler saying the risk/reward is balanced with material downward revisions to estimates likely limited. 3. AstraZeneca (AZN) upgraded to Outperform from Neutral at Credit Suisse with analyst Rebekah Harper saying that after recent pipeline success for Tagrisso and Imfinzi, she sees a marked improvement in its strategic position in pricing power and replacement power. 4. KKR (KKR) upgraded to Buy from Neutral at Goldman Sachs with analyst Alexander Blostein citing a more stable, improving mix of balance sheet investments, lower concentration in large public holdings, and increased mix towards private holdings. 5. Groupon (GRPN) upgraded to Market Perform from Underperform at Cowen with analyst Thomas Champion saying he believes the shares currently look more attractive given the company's new management and cost controls, improved North America results, and balanced expectations for the second half of 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CUTR Cutera
$40.60

1.1 (2.78%)

06/27/17
GABE
06/27/17
NO CHANGE
GABE
Buy
Cutera named a 2H 2017 best idea at Gabelli
Gabelli analyst Jennie Tsai named Cutera saying new leadership in various regions along with a renewed focus to drive sustainable growth make it a second half 2017 best idea. The analyst expects increased revenue through sales force expansion and new products and said recent M&A among laser dermatology companies will provide opportunities to drive sustainable growth and market share. Cutera is Buy rated with a $33 price target.
08/08/17
ROTH
08/08/17
NO CHANGE
Target $39
ROTH
Buy
Cutera price target raised to $39 from $32 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for Cutera to $39 from $32 after the company reported a "robust" Q2 beat and raised its full-year revenue and EPS outlook. The analyst reiterates a Buy rating on the shares.
09/14/17
09/14/17
DOWNGRADE

Hold
Follow-up: Cutera downgraded to Hold from Buy at Maxim
As previously reported, Maxim downgraded Cutera to Hold from Buy with a $33 price target. Analyst Anthony Vendetti changed is view citing valuation and difficult year--over-year comps ahead.
09/12/17
ROTH
09/12/17
NO CHANGE
Target $47
ROTH
Buy
Cutera price target raised to $47 from $41 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for Cutera to $47 from $41 after meeting with management. The analyst came away with a bullish view on the company's "meaningful" future growth opportunity with truSculpt in the large and high-growth body contouring market, an aspect which he believes remains underappreciated. Lewis reiterates a Buy rating on the shares.
TESO Tesco
$4.05

0.1 (2.53%)

04/10/17
04/10/17
NO CHANGE

FBR views Tesco as most likely takeover in Oilfield Services
FBR Capital analyst Thomas Curran says that within his Oilfield Services coverage, Tesco (TESO) has the highest probability of a straight acquisition. In GE Oil & Gas (GE) and Forum Energy (FET), Tesco has at least two potential strategic acquirers with "highly compelling logic," Curran tells investors in a research note. He believes a buyer could offer $10 per share. Tesco closed Friday at $7.30.
08/18/17
GHSC
08/18/17
UPGRADE
Target $8
GHSC
Buy
Nabors Industries upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Mike Urban upgraded Nabors (NBR) Industries to Buy with an $8 price target and updated estimates for the recently announced acquisition of Tesco (TESO). The analyst thinks Nabors is doing more than peers to drive revenue and margin growth and thinks shares already discount sharply lower oil prices and views valuation as attractive even on his below consensus estimates.
01/19/17
COWN
01/19/17
DOWNGRADE
Target $10
COWN
Market Perform
Tesco downgraded to Market Perform from Outperform at Cowen
Cowen analyst Marc Bianchi downgraded Tesco to Market Perform citing valuation and raised its price target to $10 from $9.
12/22/16
BOFA
12/22/16
INITIATION
Target $6
BOFA
Underperform
Tesco initiated with an Underperform at BofA/Merrill
BofA/Merrill analyst J.B. Lowe initiated Tesco with an Underperform and a $6 price target saying he believes new equipment sales will lag in the early stages of a recovery given the large oversupply in both onshore and offshore rigs
NBR Nabors Industries
$6.08

0.13 (2.18%)

11/08/17
JEFF
11/08/17
UPGRADE
Target $9
JEFF
Buy
Nabors Industries upgraded to Buy from Hold at Jefferies
Jefferies analyst Brad Handler upgraded Nabors Industries (NBR) to Buy citing visibility into free cash flow and earnings upside potential. The analyst raised his price target for the shares to $9 from $8. The analyst sees "incremental positives" for drillers including a path to activity and dayrate increases through 2018. His preference rank order within drilling is Patterson-UTI (PTEN), Precision Drilling (PDS), Nabors and Helmerich & Payne (HP).
10/10/17
DBAB
10/10/17
INITIATION
Target $9
DBAB
Hold
Nabors Industries initiated with a Hold at Deutsche Bank
Deutsche Bank analyst David Havens started Nabors Industries with a Hold rating and $9 price target.
08/31/17
SOCG
08/31/17
INITIATION
Target $7
SOCG
Hold
Nabors Industries initiated with a Hold at Societe Generale
Societe Generale analyst Edward Muztafago initiated Nabors Industries with a Hold and a $7 price target due to limited leverage and a backdrop of "lower for longer" oil pricing.

TODAY'S FREE FLY STORIES

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

, LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

05:20
12/15/17
12/15
05:20
12/15/17
05:20
Recommendations
Campbell Soup, Snyder's-Lance analyst commentary  »

Campbell deal for…

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.87

0.84 (1.01%)

05:16
12/15/17
12/15
05:16
12/15/17
05:16
Recommendations
Tesaro analyst commentary  »

Tesaro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:13
12/15/17
12/15
05:13
12/15/17
05:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRC

First Republic

$88.54

-0.27 (-0.30%)

05:11
12/15/17
12/15
05:11
12/15/17
05:11
Downgrade
First Republic rating change  »

First Republic downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.87

0.84 (1.01%)

05:10
12/15/17
12/15
05:10
12/15/17
05:10
Hot Stocks
Tesaro announces availability of Zejula in Germany »

Tesaro announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$31.11

0.05 (0.16%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Hot Stocks
Hutchison China MediTech initiates fruquintinib U.S. clinical trials »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

, CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Recommendations
Snyder's-Lance, Campbell Soup analyst commentary  »

Snyder's-Lance worth…

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$57.31

-0.38 (-0.66%)

05:07
12/15/17
12/15
05:07
12/15/17
05:07
Hot Stocks
CSX announces medical leave of CEO, COO James Foote named acting CEO »

CSX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:03
12/15/17
12/15
05:03
12/15/17
05:03
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:00
12/15/17
12/15
05:00
12/15/17
05:00
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SON

Sonoco Products

$53.13

-0.6 (-1.12%)

04:59
12/15/17
12/15
04:59
12/15/17
04:59
Upgrade
Sonoco Products rating change  »

Sonoco Products upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

, AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

04:58
12/15/17
12/15
04:58
12/15/17
04:58
Upgrade
Sealed Air, Avery Dennison rating change  »

Sealed Air upgraded to…

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.80

-0.1 (-0.92%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Initiation
Hi-Crush Partners initiated  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.49

-0.35 (-0.66%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
MetLife to hold a conference call »

Investor outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

  • 12

    Jun

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

November Industrial…

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Breaking General news story  »

Week of 12/15…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Cable, Media &…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

DIS

Disney

$110.57

2.96 (2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production to be reported at 09:15 »

November Industrial…

ADRNY

Ahold Delhaize

$21.69

-0.14 (-0.64%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Ahold Delhaize management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

BASFY

BASF

$27.57

-0.17 (-0.61%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
BASF management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

CUTR

Cutera

$47.20

-1.3 (-2.68%)

, TESO

Tesco

$3.70

-0.25 (-6.33%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Hot Stocks
Cutera to replace Tesco in S&P 600 at open on 12/15 »

MidCap 400 constituent…

CUTR

Cutera

$47.20

-1.3 (-2.68%)

TESO

Tesco

$3.70

-0.25 (-6.33%)

NBR

Nabors Industries

$5.58

-0.23 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

RCKZF

Rocket Internet

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Rocket Internet management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

PJT

PJT Partners

$44.10

-0.24 (-0.54%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
PJT Partners management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

JAGX

Jaguar Health

$0.13

0.0068 (5.52%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Jaguar Health to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.